Septerna
San Francisco
About Septerna
Septerna is a biotechnology company that discovers and advances novel small-molecule medicines targeting G protein-coupled receptors. The company's mission is to discover, develop, and commercialize medicines that improve the lives of patients by combining GPCR drug targets with the power of state-of-the-art small molecule drug discovery technologies. Septerna’s Native Complex platform is the engine that will make this happen.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 51 – 100
- Estimated revenue: $1K – $10K
- Total funding: $250.0M
- Funding stage: M&A
- Last round: Series B (Jul 2023)
- Ticker: nasdaq:SEPN
- Website: septerna.com
- Phone: 650-338-3533
Industries & Categories
Biotechnology, Information Technology, Medical, Software
Social Profiles
Canonical: https://fsome.com/organization/septerna-103196 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.